Literature DB >> 21061514

[Guidelines for the clinical management of allergic conjunctival disease (2nd edition)].

.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21061514

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN： 0029-0203


× No keyword cloud information.
  4 in total

1.  Changes in corneal endothelial cell shape after treatment with one drop of ROCK inhibitor.

Authors:  Riyo Matsumura; Kenji Inoue; Minako Shiokawa; Madoka Ono; Hidenobu Tanihara; Kyoko Ishida; Goji Tomita
Journal:  Int Ophthalmol       Date:  2019-10-29       Impact factor: 2.031

2.  Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma.

Authors:  Yoko Ikeda; Kazuhiko Mori; Kaori Tada; Morio Ueno; Shigeru Kinoshita; Chie Sotozono
Journal:  Clin Ophthalmol       Date:  2016-08-24

3.  Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial.

Authors:  Emi Sakamoto; Waka Ishida; Tamaki Sumi; Tatsuma Kishimoto; Kentaro Tada; Ken Fukuda; Tsuyoshi Yoneda; Hajime Kuroiwa; Etsuko Terao; Yasuko Fujisawa; Shunsuke Nakakura; Koji Jian; Hideaki Okumichi; Yoshiaki Kiuchi; Atsuki Fukushima
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

4.  Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination.

Authors:  Kenji Inoue; Hua Piao; Mayumi Iwasa; Kyoko Ishida; Goji Tomita
Journal:  Clin Ophthalmol       Date:  2020-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.